Dr. Menon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1144 Eastlake Ave E, Seattle WA
Seattle, WA 98109Phone+1 855-557-0555
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2004 - 2007- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2002 - 2004
University of ConnecticutInternship, Internal Medicine, 2001 - 2002
Stanley Medical College SMCClass of 1999
Certifications & Licensure
ID State Medical License 2024 - 2025
WA State Medical License 2022 - 2025
WI State Medical License 2010 - 2023
MN State Medical License 2003 - 2012
TX State Medical License 2010 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsHigh-Grade Pneumonitis Events in Patients With Unresectable, Locally Advanced NSCLC Treated With Definitive Chemoradiation Followed by Adjuvant Durvalumab.Ciani Ellison, Michael Martens, Juliana Alvarez Argote, Samantha Benz, Adam Currey
JTO Clinical and Research Reports. 2024-12-01 - 4 citationsMulticenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy.Charles B Simone 2nd, Artur A Serebrenik, Elizabeth M Gore, Pranshu Mohindra, Stephen L Brown
International Journal of Radiation Oncology, Biology, Physics. 2024-02-01 - 4 citationsComprehensive genomic profiling: Does timing matter?Bicky Thapa, Gulrayz Ahmed, Aniko Szabo, Mandana Kamgar, Deepak Kilari
Frontiers in Oncology. 2023-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
